BackDirexion Shares ETF Trust - Direxion mRNA ETF Overview

Direxion Shares ETF Trust - Direxion mRNA ETF Total Current Liabilities

Track Direxion Shares ETF Trust - Direxion mRNA ETF's total current liabilities ($260M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$255.75M

Peer trimmed avg / median

Loading

Direxion Shares ETF Trust - Direxion mRNA ETF Total Current Liabilities History

Loading

Direxion Shares ETF Trust - Direxion mRNA ETF vs. peers: Total Current Liabilities Comparison

Loading

Direxion Shares ETF Trust - Direxion mRNA ETF Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Direxion Shares ETF Trust - Direxion mRNA ETF (MSGR) FAQ

The latest total current liabilities for MSGR is $260M as of September 2026. Investors often review this figure alongside Direxion Shares ETF Trust - Direxion mRNA ETF's historical trend and sector peers before judging valuation or financial health.

A total current liabilities figure of $260M for MSGR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MSGR's total current liabilities ($260M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.